- Research works
- 30 ▲ 63% vs 2013–17
- Citations
- 576 19.1 per fractional work
- Top-10% rate
- 6.0% record average 16.5%
- Open access
- 31% world 28%
Not ranked overall: Pluristem Therapeutics (Israel) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 20.7×. Every wedge is a field page.
Which keywords describe research at Pluristem Therapeutics (Israel)?
By fractional works in all years, weighted toward what it does more of than the world: Mesenchymal Stem Cells, Differentiation, Transplantation, Regeneration, Immunomodulation, Multipotent, Regenerative Medicine and Immunotherapy.
- Radiotherapy
- Decellularization
- Stem Cell Therapy
- Placental Development
- Extracellular Matrix
- Arginine Deprivation
- Tumor Regression
- Induced Pluripotent Stem Cells
- Embryonic Stem Cells
- Graft-versus-Host Disease
- Bone Marrow Niche
- Hematopoietic Stem Cells
- Pluripotent Stem Cells
- Regenerative Medicine
- Multipotent
- Transplantation
- Differentiation
- Mesenchymal Stem Cells
- Regeneration
- Immunomodulation
- Oxidative Stress
- Immunotherapy
- Inflammation
- Tumor Targeting
- Cancer
- Cancer Therapy
- Gene Therapy
- Maternal Mortality
- Apoptosis
- Bacterial Therapy
- Immunity
- Preeclampsia
- Cancer Stem Cells
- Organ Engineering
- Tumor Metastasis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 35 words, with their numbers
- Mesenchymal Stem Cells8▲ 209×2 topics
- Differentiation7▲ 326×2 topics
- Regeneration6▲ 111×2 topics
- Transplantation6▲ 175×2 topics
- Immunomodulation6▲ 133×1 topic
- Multipotent6▲ 507×1 topic
- Oxidative Stress2▲ 3.8×6 topics
- Regenerative Medicine2▲ 31×3 topics
- Immunotherapy2▲ 10×7 topics
- Pluripotent Stem Cells2▲ 95×2 topics
- Inflammation2▲ 2.5×5 topics
- Hematopoietic Stem Cells2▲ 51×2 topics
- Tumor Targeting2▲ 41×3 topics
- Bone Marrow Niche2▲ 146×1 topic
- Cancer2▲ 3.4×4 topics
- Graft-versus-Host Disease2▲ 146×1 topic
- Cancer Therapy1▲ 6.6×4 topics
- Embryonic Stem Cells1▲ 59×1 topic
- Gene Therapy1▲ 17×2 topics
- Induced Pluripotent Stem Cells1▲ 124×1 topic
- Maternal Mortality1▲ 22×2 topics
- Tumor Regression1▲ 45×2 topics
- Apoptosis1▲ 9.4×2 topics
- Arginine Deprivation1▲ 82×1 topic
- Bacterial Therapy1▲ 82×1 topic
- Extracellular Matrix1▲ 15×2 topics
- Immunity1▲ 11×2 topics
- Placental Development1▲ 58×1 topic
- Preeclampsia1▲ 47×1 topic
- Stem Cell Therapy1▲ 38×2 topics
- Cancer Stem Cells1▲ 77×1 topic
- Decellularization1▲ 89×1 topic
- Organ Engineering1▲ 89×1 topic
- Radiotherapy1▲ 9.0×2 topics
- Tumor Metastasis1▲ 55×1 topic
Which research topics does Pluristem Therapeutics (Israel) publish most on?
By volume in 2022–2025: Mesenchymal stem cell research, Nerve injury and regeneration, Neurogenesis and neuroplasticity mechanisms and Effects of Radiation Exposure.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Mesenchymal stem cell research Genetics 0 works
- 2 Nerve injury and regeneration Cellular and Molecular Neuroscience 0 works
- 3 Neurogenesis and neuroplasticity mechanisms Developmental Neuroscience 0 works
- 4 Effects of Radiation Exposure Radiology, Nuclear Medicine and Imaging 0 works
- 5 Neuroinflammation and Neurodegeneration Mechanisms Neurology 0 works
- 6 Lymphatic System and Diseases Oncology 0 works
- 7 Nanoparticle-Based Drug Delivery Biomaterials 0 works
- 8 Knee injuries and reconstruction techniques Surgery 0 works
- 9 Tendon Structure and Treatment Orthopedics and Sports Medicine 0 works
- 10 Graphene and Nanomaterials Applications Biomedical Engineering 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pluristem Therapeutics (Israel)'s research output changed?
Output in 2018–2022 was 63% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Haifa
- Technion – Israel Institute of Technology
- University of Haifa
- Rambam Health Care Campus
- Rafael Advanced Defense Systems (Israel)
- Rappaport Family Institute for Research in the Medical Sciences
- Carmel Medical Center
- Bnai Zion Medical Center
- Israel Oceanographic and Limnological Research
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.